|
|
|
Volumn 16, Issue 4, 2006, Pages 95-103
|
|
Monoclonal antibody targeting RANKL as a therapy for cancer-induced bone diseases
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARRIER PROTEIN;
DENOSUMAB;
MEMBRANE PROTEIN;
MONOCLONAL ANTIBODY;
OSTEOCLAST DIFFERENTIATION FACTOR;
RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;
TNFRSF11A PROTEIN, HUMAN;
TNFSF11 PROTEIN, HUMAN;
ANIMAL;
BONE DISEASE;
HUMAN;
IMMUNOLOGY;
NEOPLASM;
PHASE 1 CLINICAL TRIAL;
REVIEW;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BONE DISEASES;
CARRIER PROTEINS;
CLINICAL TRIALS, PHASE I;
HUMANS;
MEMBRANE GLYCOPROTEINS;
NEOPLASMS;
RANK LIGAND;
RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;
|
|
EID: 33745314518
PISSN: 09175857
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (13)
|
|
References (43)
|
